HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senators Ask For FDA Action On 1,4-Dioxane; EWG Surveying Industry

This article was originally published in The Rose Sheet

Executive Summary

Eliminating any trace of 1,4-dioxane from personal-care products may be an impossibility, but a pair of US senators believe companies should be required to use manufacturing techniques that can minimize the contaminant’s presence. The Environmental Working Group is following up on their citizen petition to FDA by surveying companies whose products may contain the suspected carcinogen in trace amounts.

You may also be interested in...



New York On Verge Of Setting Limits For 1,4-Dioxane In Cosmetic Products

Cosmetic cleansing products containing 1,4-dioxane at levels above 1 part per million would be unlawfully marketed in New York beginning in 2023 under legislation passed by the state’s legislature in June. Governor Andrew Cuomo reportedly is reviewing the bill.

Cleaning Product Bills' Fate Could Bear On Cosmetic Disclosure Efforts

If proposed cleaning product "right to know" legislation were to pass in California or US Congress, it could put new wind in NGOs' sails, powering efforts to unmask fragrance ingredients and contaminants lurking in cosmetics.

FDA Moves To Dismiss NGOs’ Hair-Smoother Lawsuit, Says Safety Review Is Nearly Complete

Facing a lawsuit from the Environmental Working Group and Women’s Voice for the Earth, FDA responds to EWG’s five-year-old petition asking the agency to review the health risks of heated hair smoothers that contain or release formaldehyde, with a view toward a potential ban. FDA says it is wrapping up its investigation, which could prompt rulemaking on the issue, and moves to dismiss the suit as moot.

Related Content

Topics

UsernamePublicRestriction

Register

RS109195

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel